A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo
Open Access
- 1 October 2019
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (19)
Abstract
Recent progress in understanding the human immune response to respiratory syncytial virus has paved the way for new vaccine antigens and therapeutics to prevent and treat disease. Progress toward understanding the immune response to human metapneumovirus (hMPV) has lagged behind, although hMPV is a leading cause of lower respiratory tract infection in children. In this report, we advanced the field by isolating a panel of human mAbs to the hMPV F protein. One potent neutralizing mAb, MPV364, targets antigenic site III on the hMPV F protein and incorporates two protomers into its epitope yet is unique from previously discovered site III mAbs, as it does not cross-react with the RSV F protein. We further examined MPV364 in vivo and found that it limits viral replication in BALB/c mice. Altogether, these data provide new mAb candidates for therapeutic development and provide insights into hMPV vaccine development.Keywords
Funding Information
- University of Georgia Office of the Vice President for Research
- University of Georgia Center for Vaccines and Immunology
- University of Georgia Department of Infectious Diseases
This publication has 55 references indexed in Scilit:
- Human Metapneumovirus in AdultsViruses, 2013
- The Human Metapneumovirus Fusion Protein Mediates Entry via an Interaction with RGD-Binding IntegrinsJournal of Virology, 2012
- Structure of the human metapneumovirus fusion protein with neutralizing antibody identifies a pneumovirus antigenic siteNature Structural & Molecular Biology, 2012
- Human Metapneumovirus: Lessons Learned over the First DecadeClinical Microbiology Reviews, 2011
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing EpitopesJournal of Virology, 2011
- Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigenNature Protocols, 2009
- Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirusJournal of General Virology, 2008
- IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysisNucleic Acids Research, 2008
- A Recombinant Human Monoclonal Antibody to Human Metapneumovirus Fusion Protein That Neutralizes Virus In Vitro and Is Effective Therapeutically In VivoJournal of Virology, 2007
- Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human Metapneumovirus In Vitro and In VivoJournal of Virology, 2006